Nanotechnology Breakthrough Makes Cancer Immunotherapy More Effective Against Solid Tumors

Preclinical study uses nanoparticles to attach immune-activating molecules to tumors, sensitizing them to immunotherapy. Scientists have developed a nanotechnology platform that can change the way the immune system sees solid tumor cells, making them more receptive to immunotherapy. This adaptable immune conversion approach has the potential for broad application across many cancer types, according to preclinical findings.